×
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
S&P 500   3,774.97 (-0.28%)
DOW   30,695.57 (-0.26%)
QQQ   278.94 (-0.48%)
AAPL   136.97 (+0.18%)
MSFT   256.57 (-0.10%)
META   157.00 (-2.64%)
GOOGL   2,150.08 (-1.34%)
AMZN   107.99 (+1.68%)
TSLA   673.21 (-0.03%)
NVDA   146.24 (-3.53%)
NIO   21.12 (-2.76%)
BABA   115.18 (+1.32%)
AMD   73.61 (-3.74%)
MU   52.58 (-4.88%)
CGC   2.85 (+0.35%)
T   21.05 (+0.43%)
GE   63.03 (-1.01%)
F   11.22 (+0.81%)
DIS   95.10 (+0.74%)
AMC   13.51 (-0.30%)
PFE   51.75 (-1.30%)
PYPL   70.31 (+0.67%)
NFLX   176.67 (+1.03%)
NYSE:EHC

Encompass Health Stock Forecast, Price & News

$45.96
-10.09 (-18.00%)
(As of 07/1/2022 12:27 PM ET)
Add
Compare
Today's Range
$44.43
$46.44
50-Day Range
$53.98
$68.83
52-Week Range
$53.03
$85.75
Volume
25,516 shs
Average Volume
852,683 shs
Market Capitalization
$4.59 billion
P/E Ratio
11.75
Dividend Yield
1.97%
Price Target
$79.56
30 days | 90 days | 365 days | Advanced Chart

Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Stock Forecast (MarketRank)

Overall MarketRank

3.36 out of 5 stars

Medical Sector

9th out of 1,429 stocks

Hospitals Industry

1st out of 5 stocks

Analyst Opinion: 3.6Community Rank: 4.9Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 2.5 5 -4 -3 -2 -1 -
Encompass Health logo

About Encompass Health (NYSE:EHC)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

EHC Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
42192430
Employees
43,400
Year Founded
1984

Company Calendar

Ex-Dividend for 4/18 Dividend
3/31/2022
Dividend Payable
4/18/2022
Last Earnings
4/27/2022
Today
7/01/2022
Ex-Dividend for 7/20 Dividend
7/12/2022
Dividend Payable
7/20/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$79.56
High Stock Price Forecast
$98.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+73.1%
Consensus Rating
Buy
Rating Score (0-4)
3.11111111111111
Research Coverage
9 Analysts

Profitability

Net Income
$412.20 million
Pretax Margin
12.08%

Debt

Sales & Book Value

Annual Sales
$5.12 billion
Cash Flow
$5.54 per share
Book Value
$23.69 per share

Miscellaneous

Free Float
97,108,000
Market Cap
$4.59 billion
Optionable
Optionable
Beta
0.96

Social Links















Encompass Health Frequently Asked Questions

Should I buy or sell Encompass Health stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health
or view top-rated stocks.

What is Encompass Health's stock price forecast for 2022?

9 analysts have issued twelve-month price targets for Encompass Health's stock. Their EHC stock forecasts range from $70.00 to $98.00. On average, they predict Encompass Health's stock price to reach $79.56 in the next year. This suggests a possible upside of 73.1% from the stock's current price.
View analysts' price targets for Encompass Health
or view top-rated stocks among Wall Street analysts.

How has Encompass Health's stock performed in 2022?

Encompass Health's stock was trading at $65.26 at the beginning of the year. Since then, EHC shares have decreased by 29.6% and is now trading at $45.96.
View the best growth stocks for 2022 here
.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Encompass Health
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) posted its quarterly earnings results on Wednesday, April, 27th. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.32 billion. Encompass Health had a trailing twelve-month return on equity of 17.99% and a net margin of 7.51%. Encompass Health's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.05 earnings per share.
View Encompass Health's earnings history
.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health declared a quarterly dividend on Thursday, May 5th. Investors of record on Wednesday, July 13th will be paid a dividend of $0.28 per share on Wednesday, July 20th. This represents a $1.12 annualized dividend and a yield of 2.44%. The ex-dividend date is Tuesday, July 12th.
View Encompass Health's dividend history
.

Is Encompass Health a good dividend stock?

Encompass Health(NYSE:EHC) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.97%. The dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY 2022 earnings guidance on Tuesday, June, 28th. The company provided earnings per share (EPS) guidance of $3.76-$4.05 for the period, compared to the consensus estimate of $4.12. The company issued revenue guidance of $5.33 billion-$5.42 billion, compared to the consensus revenue estimate of $5.46 billion.

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 60, Pay $3.04M)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 60, Pay $1.65M)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 57)
  • Ms. Barbara Ann Jacobsmeyer, Chief Exec. Officer of Home Health & Hospice (Age 56)
  • Ms. Elissa Joy Charbonneau, Chief Medical Officer (Age 62, Pay $676.46k) (LinkedIn Profile)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 54) (LinkedIn Profile)
  • Mr. Rusty Yeager, Chief Information Officer & Sr. VP
  • Mr. Mark Miller, Sr. VP of Investor Relations & Strategic Planning
  • Ms. Dawn Rock, Chief Compliance Officer
  • Mr. Anthony A. Hernandez, Chief HR Officer (Age 56)

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $45.96.

How much money does Encompass Health make?

Encompass Health (NYSE:EHC) has a market capitalization of $4.59 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.909990 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,400 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for Encompass Health is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719.

This page (NYSE:EHC) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.